檢索結果 - Mary Peterman
- Showing 1 - 1 results of 1
-
1
Translational findings support regimen selection for first‐in‐human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer 由 Min Zhu, Priyanka Madia, Alison Crawford, Jurriaan Brouwer‐Visser, Pamela Krueger, Lauric Haber, Mary Peterman, Thomas S. Uldrick, Elizabeth Miller, John D. Davis, Marc W. Retter
發表在 Clinical and Translational Science (2024-12-01)獲取全文
Article